what is considered a low dose of glp 1 practical guide to introducing and titrating GLP-1 therapies GLP-1s 101: What the science

Alyssa Dominguez, an endocrinologist at Keck Medicine of USC

doi: 10.1016/S2213-8587(24)00271-7 [DOI] [PubMed] [Google Scholar] 34.Marx N, Husain M, Lehrke M, Verma S, Sattar N

Animal studies have also shown that portal vein GLP-1 weakens intestinal fat absorption and chylomicron production through the vagal enteric-brain-liver axis, and reduces postprandish and fasting blood lipids [79]

Additionally, microdosing is unlikely to deliver the clinically proven weight loss associated with standard dosing

& Spada, A

Retatrutide is an investigational peptide being studied for its potential role in metabolic and weight management within controlled research settings under medical supervision